We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
-23.06%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
10 Year Est. Return
AUM
$68M
AUM Growth
-$29.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIRM icon
1
Mirum Pharmaceuticals
MIRM
$6.08B
$37.4M 54.94%
1,921,118
ALLK
2
DELISTED
Allakos
ALLK
$15.3M 22.48%
4,887,932
OKUR
3
OnKure Therapeutics
OKUR
$155M
$6.38M 9.38%
240,922
XLO icon
4
Xilio Therapeutics
XLO
$59.3M
$4.21M 6.19%
102,960
SPRB
5
Spruce Biosciences
SPRB
$182M
$3.74M 5.49%
28,644
VAPO
6
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$1.03M 1.51%
50,896

Similar funds

RiverVest Venture Management's Q2 2022 Portfolio in Review

As of Q2 2022, RiverVest Venture Management held 6 positions worth $68M, down 30% from $97.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. RiverVest Venture Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's ten largest holdings make up 100% of its $68M portfolio in Q2 2022.
  • RiverVest Venture Management opened 0 new positions and closed 0 in Q2 2022.
  • RiverVest Venture Management's portfolio value fell 30% quarter-over-quarter to $68M.

Based on RiverVest Venture Management's 13F filing for Q2 2022, filed 10 Aug 2022.